Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ:: a nested case-control study

被引:256
|
作者
Ylitalo, N
Sorensen, P
Josefsson, AM
Magnusson, PKE
Andersen, PK
Pontén, J
Adami, HO
Gyllensten, UB
Melbye, M
机构
[1] Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden
[2] Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark
[3] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden
[4] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
[5] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA
来源
LANCET | 2000年 / 355卷 / 9222期
关键词
D O I
10.1016/S0140-6736(00)02402-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Persistent infection with certain types of human papillomavirus (HPV) is believed to be a prerequisite for the development of cervical neoplasia. Persistence may depend on certain characteristics, such as viral load, which has so far been given little attention. We investigated the association between HPV 16 viral load and cervical carcinoma in situ. Methods We did a nested case-control study of women participating in cytological screening in Sweden. We used a sensitive quantitative PCR assay to estimate HPV 16 load in multiple smears for each woman, taken during a period of up to 26 years before diagnosis. We calculated C-t values, which decrease as the number of viral DNA copies increases. Findings 2081 smears from 478 cases and 1754 smears from 608 controls were tested. Among cases, we found a consistently increased load of HPV 16 already 13 years or more before diagnosis, and when many smears were still cytologically normal. Women with high HPV 16 viral loads were at least 30 times the relative risk of HPV-16-negative women more than a decade before diagnosis. The increase in relative risk was constant over time. About 25% of women (95% CI 0.12-0.32) infected with a high viral load before age 25 years developed cervical carcinoma in situ within 15 years. Interpretation Cervical carcinoma in situ associated with HPV 16 occurs mainly in HPV-16-positive women who have consistently high viral loads long term. Women at high risk could be identified by use of a quantitative HPV test in addition to cytological screening.
引用
收藏
页码:2194 / 2198
页数:5
相关论文
共 50 条
  • [21] Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk:: nested case-control study
    Naucler, Pontus
    Chen, Hui-Chi
    Persson, Kenneth
    You, San-Lin
    Hsieh, Chang-Yao
    Sun, Chien-An
    Dillner, Joakim
    Chen, Chien-Jen
    JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 814 - 822
  • [22] HUMAN PAPILLOMAVIRUS INFECTION AND OTHER RISK-FACTORS FOR CERVICAL NEOPLASIA - A CASE-CONTROL STUDY
    MORRISON, EAB
    HO, GYF
    VERMUND, SH
    GOLDBERG, GL
    KADISH, AS
    KELLEY, KF
    BURK, RD
    INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) : 6 - 13
  • [23] Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ
    Moberg, M
    Gustavsson, I
    Gyllensten, U
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (05) : 854 - 859
  • [24] Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
    Kim, Gyuri
    Jang, Suk-Yong
    Nam, Chung Mo
    Kang, Eun Seok
    JOURNAL OF HEPATOLOGY, 2018, 68 (03) : 476 - 484
  • [25] Association of Human Papillomavirus Genotype 16 Viral Variant and Viral Load with Cervical High-grade Intraepithelial Lesions
    Alvarez-Paredes, Ledicia
    Santibanez, Miguel
    Galiana, Antonio
    Rodriguez Diaz, Juan Carlos
    Paras-Bravo, Paula
    Encarnacion Andrada-Becerra, Ma
    Ruiz Garcia, Maria Montserrat
    Maria Rodriguez-Ingelmo, Jose
    Portilla-Sogorb, Joaquin
    Paz-Zulueta, Maria
    CANCER PREVENTION RESEARCH, 2019, 12 (08) : 547 - 555
  • [26] Viral load of human papillomavirus 16 as a predictive and diagnostic marker for cervical intraepithelial neoplasia and carcinoma of cervix.
    Kim, BK
    Chung, HH
    Seo, SS
    Dong, SM
    Shin, HR
    Park, SY
    Roh, JW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1869S - 1869S
  • [27] Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study
    Naucler, Pontus
    da Costa, Flora Mabota
    da Costa, Joao Leopoldo
    Ljungberg, Otto
    Bugalho, Antonio
    Dillner, Joakim
    JOURNAL OF GENERAL VIROLOGY, 2011, 92 : 2784 - 2791
  • [28] Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer
    Arias-Pulido, Hugo
    Peyton, Cheri L.
    Joste, Nancy E.
    Vargas, Hernan
    Wheeler, Cosette M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (05) : 1755 - 1762
  • [29] Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
    Lei, Jiayao
    Andrae, Bengt
    Ploner, Alexander
    Lagheden, Camilla
    Eklund, Carina
    Kleppe, Sara Nordqvist
    Wang, Jiangrong
    Fang, Fang
    Dillner, Joakim
    Elfstrom, K. Miriam
    Sparen, Par
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [30] A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections
    Rousseau, MC
    Franco, EL
    Villa, LL
    Sobrinho, JP
    Termini, L
    Prado, JM
    Rohan, TE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (05) : 469 - 476